These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Beta-2-microglobulin removal by hemodialysis with polymethylmethacrylate membranes. Campistol JM; Torregrosa JV; Ponz E; Fenollosa B Contrib Nephrol; 1999; 125():76-85. PubMed ID: 9895432 [No Abstract] [Full Text] [Related]
3. Hemofiltration and the middle molecule. Henderson LW Blood Purif; 1999; 17(4):175-7. PubMed ID: 10494018 [No Abstract] [Full Text] [Related]
4. Quantitative and qualitative assessment and clinical meaning of molecules removed with BK membranes. Buoncristiani U; Galli F; Benedetti S; Errico R; Beninati S; Ghibelli L; Floridi A; Canestrari F Contrib Nephrol; 1999; 125():133-58. PubMed ID: 9895437 [No Abstract] [Full Text] [Related]
5. High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results. David S; Cambi V Contrib Nephrol; 1999; 125():96-110. PubMed ID: 9895434 [No Abstract] [Full Text] [Related]
6. Structural and functional characteristics of currently available PMMA dialyzers. Ghezzi PM; Meinero S; Ronco C Contrib Nephrol; 1999; 125():25-40. PubMed ID: 9895428 [No Abstract] [Full Text] [Related]
7. Biocompatibility of PMMA membranes in acute and chronic patients with renal failure. Manzoni C; Locatelli F Contrib Nephrol; 1999; 125():65-75. PubMed ID: 9895431 [No Abstract] [Full Text] [Related]
8. Choice of modality with the use of high-performance membrane and evaluation for clinical effects. Masakane I Contrib Nephrol; 2011; 173():84-94. PubMed ID: 21865780 [TBL] [Abstract][Full Text] [Related]
9. Identification of an erythropoietic inhibitor from the dialysate collected in the hemodialysis with PMMA membrane (BK-F). Yamada S; Kataoka H; Kobayashi H; Ono T; Minakuchi J; Kawano Y Contrib Nephrol; 1999; 125():159-72. PubMed ID: 9895438 [No Abstract] [Full Text] [Related]
11. First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis. Ronco C; Brendolan A; Winchester JF; Golds E; Clemmer J; Polaschegg HD; Muller TE; La Greca G ; Levin NW Blood Purif; 2001; 19(2):260-3. PubMed ID: 11150821 [No Abstract] [Full Text] [Related]
12. Anemia of hemodialysis patients: evaluation of the effect of BK-F polymethylmethacrylate membrane. Locatelli F; Andrulli S; Del Vecchio L Contrib Nephrol; 1999; 125():173-81. PubMed ID: 9895439 [No Abstract] [Full Text] [Related]
13. Polymethylmethacrylate: one biomaterial for a series of membrane. Takeyama T; Sakai Y Contrib Nephrol; 1999; 125():9-24. PubMed ID: 9895427 [No Abstract] [Full Text] [Related]
14. Biocompatible characteristics of high-performance membranes. Uda S; Mizobuchi M; Akizawa T Contrib Nephrol; 2011; 173():23-29. PubMed ID: 21865772 [TBL] [Abstract][Full Text] [Related]
15. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role? Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845 [TBL] [Abstract][Full Text] [Related]
17. Albumin loss under the use of the high-performance membrane. Tsuchida K; Minakuchi J Contrib Nephrol; 2011; 173():76-83. PubMed ID: 21865779 [TBL] [Abstract][Full Text] [Related]
18. Polymethylmethacrylate membrane with a series of serendipity. Sakai Y Contrib Nephrol; 2011; 173():137-147. PubMed ID: 21865786 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new polyamide membrane (Polyflux 130) in high-flux dialysis. Schaefer RM; Gilge U; Goehl H; Heidland A Blood Purif; 1990; 8(1):23-31. PubMed ID: 2198889 [TBL] [Abstract][Full Text] [Related]
20. Required water quality for the use of high-performance membranes. Aoike I Contrib Nephrol; 2011; 173():53-57. PubMed ID: 21865776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]